Status:
COMPLETED
Efficacy and Safety of a Purified Standardised Wasp Venom Preparation
Lead Sponsor:
Allergopharma GmbH & Co. KG
Conditions:
Allergy
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy
Eligibility Criteria
Inclusion
- History of wasp venom allergy,
- Positive RAST to wasp venom,
- Positive skin prick test to wasp venom
Exclusion
- Serious chronic diseases
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
End Date :
November 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00263926
Start Date
March 1 2001
End Date
November 1 2010
Last Update
March 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergopharma GmbH & Co. KG
Reinbek, Germany, 21465